Results 121 to 130 of about 3,018 (196)

Correction: The Effectiveness of Anti-Interleukin-17A Treatment for Pityriasis Rubra Pilaris: A Systematic Review. [PDF]

Cureus
Abduljawad M, Alsharif TH, Gronfula AG, Magadmi TK, Khayat LI, Fageeh SM, Almuallim AA, Mohammad MA, Albadri A.   +8 more
europepmc   +1 more source

Pityriasis rubra pilaris in skin of color

International Journal of Women's Dermatology, 2021
John G. Plante, BS, Ahmad I. Aleisa, MD, Bruce H. Thiers, MD   +2 more
doaj   +1 more source

Navigating the Misdiagnosis of Pityriasis Rubra Pilaris and Successful Treatment With Guselkumab: A Case Report of Dual Biologic Therapy. [PDF]

Cureus
Bongfeldt D, Martinez-Cabriales S.
europepmc   +1 more source

Efficacy of Bimekizumab in the Management of Refractory Erythrodermic Pityriasis Rubra Pilaris: Clinical Insights. [PDF]

Dermatol Pract Concept
Theotokoglou S, Sgouros D, Theodoropoulos K, Syrmali A, Pappa G, Katoulis A.   +5 more
europepmc   +1 more source

Ponatinib Induced Pityriasis Rubra Pilaris: Case Report and Review of Literature. [PDF]

Indian Dermatol Online J, 2023
Jain S, Bhandari A, Vinay K, Chatterjee D.   +3 more
europepmc   +1 more source

Kaposi's Varicelliform Eruption After Treatment With Ixekizumab in a Patient With Pityriasis Rubra Pilaris. [PDF]

Cureus, 2023
Guenther JS, Ahronowitz I, Worswick S.
europepmc   +1 more source

Sorafenib-Induced Pityriasis Rubra Pilaris-like Eruption: A Case Report. [PDF]

Indian Dermatol Online J
Patel T, Vasani P, Surani A, Shah BJ.
europepmc   +1 more source

Erythrodermic pityriasis rubra pilaris following SARS-CoV-2 vaccination treated with bimekizumab. [PDF]

JAAD Case Rep, 2023
Saad M, Bose R.
europepmc   +1 more source

Complete Resolution of Pityriasis Rubra Pilaris With Targeted Treatment: A Case Report. [PDF]

Cureus
Muzaffar KH, Albadri A.
europepmc   +1 more source

A Rare Post-infectious Rash: Pityriasis Rubra Pilaris After COVID-19 Infection. [PDF]

Cureus, 2023
Duncan P, Flood D, Dietz C.
europepmc   +1 more source